-
381“…Ipilimumab is a human monoclonal IgG1 antibody against CTLA-4 that has been shown to prolong the overall survival of advanced melanoma. The most common adverse events associated with ipilimumab are immune-related. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
382“…Abstract Iris and ciliary body melanoma is an aggressive tumor, which, unfortunately, presents symptoms only in advanced stages and is often discovered accidentally during a routine eye examination. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
383
-
384
-
385por Guillermo-Lagae, Ruth, Santha, Sreevidya, Thomas, Milton, Zoelle, Emily, Stevens, Jonathan, Kaushik, Radhey S., Dwivedi, Chandradhar“…In this study, antineoplastic effects of honokiol were investigated in malignant melanoma models. In vitro effects of honokiol treatment on SKMEL-2 and UACC-62 melanoma cells were evaluated by measuring the cell viability, proliferation, apoptosis, cell cycle analysis, and expressions of various proteins associated with cell cycle progression and apoptosis. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
386por Patel, Dhruvan, Sohrawardy, Shazia, Sedhai, Yub Raj, Basnyat, Soney, Daxini, Anisha, Basu, Aparna, Mehta, Vivek R., Mohammed, Aasim, Lichtenstein, Steven“…Metastatic melanoma is an aggressive disease that can spread to many organs of the body. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
387por Mollerup, Sarah, Fridholm, Helena, Vinner, Lasse, Kjartansdóttir, Kristín Rós, Friis-Nielsen, Jens, Asplund, Maria, Herrera, Jose A.R., Steiniche, Torben, Mourier, Tobias, Brunak, Søren, Willerslev, Eske, Izarzugaza, Jose M.G., Hansen, Anders J., Nielsen, Lars P.“…We detected cutavirus in a sample of cutaneous malignant melanoma by using viral enrichment and high-throughput sequencing. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
388“…Patients with advanced melanoma have a compromised anti-tumor immune response leading to tumor immune tolerance and a tumor microenvironment conducive to disease progression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
389“…Uveal melanoma (UM) is a severe human malignancy with a high mortality rate that demands continued research into new and alternative forms of prevention and treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
390“…Melanoma is one of the most aggressive skin cancers with fiercely increasing incidence and mortality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
391por Kinsler, V.A., O'Hare, P., Bulstrode, N., Calonje, J.E., Chong, W.K., Hargrave, D., Jacques, T., Lomas, D., Sebire, N.J., Slater, O.“…Congenital melanocytic naevi (CMN) are a known risk factor for melanoma, with the greatest risk currently thought to be in childhood. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
392por Nishiya, Adriana Tomoko, Massoco, Cristina Oliveira, Felizzola, Claudia Ronca, Perlmann, Eduardo, Batschinski, Karen, Tedardi, Marcello Vannucci, Garcia, Jéssica Soares, Mendonça, Priscila Pedra, Teixeira, Tarso Felipe, Zaidan Dagli, Maria Lucia“…Melanomas are malignant neoplasms originating from melanocytes. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
393“…Melanoma is a malignant tumor of melanocytes and is considered to be the most aggressive cancer among all skin diseases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
394“…Melanoma is a cancer that exhibits one of the most aggressive and heterogeneous features. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
395
-
396por Linck, Rudinei Diogo Marques, Costa, Rômulo Leopoldo de Paula, Garicochea, Bernardo“…Recent reports have shown efficacy and safety with the use of pembrolizumab, nivolumab, and ipilimumab for the treatment of different neoplasms, especially melanoma. In this article, we propose a review of the mechanisms of action involved in cancer immunology, the response evaluation of immunotherapies, and its toxicity profile, as well as a summary of the main clinical trials that led to the adoption of these new drugs for melanoma treatment.…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
397“…Primary melanoma of the oral cavity is extremely uncommon tumour consisting approximately 0.2 - 8.0% of all melanoma cases and 0.5% of all oral malignancies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
398“…Importance—Pediatric melanoma occurs, albeit rarely. Should patients be treated by today’s medical standards, or be subjected to medically unnecessary clinical studies? …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
399“…OBJECTIVE: The objective of the study was to summarize the role of DNA methylation in the development and metastasis of uveal melanoma (UM). DATA SOURCES: The relevant studies in MEDLINE were searched. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
400